Overview

A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

Status:
Not yet recruiting
Trial end date:
2024-10-31
Target enrollment:
Participant gender:
Summary
The main goal of this trial is to learn whether eptinezumab helps reduce the number of days with episodic migraine in pediatric participants.
Phase:
Phase 3
Details
Lead Sponsor:
H. Lundbeck A/S